Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning

Sánchez-Carro, Y; de la Torre-Luque, A; Leal-Leturia, I; Salvat-Pujol, N; Massaneda, C; de Arriba-Arnau, A; Urretavizcaya, M; Pérez-Solà, V; Toll, A; Martínez-Ruiz, A; Ferreirós-Martínez, R; Pérez, S; Sastre, J; Alvarez, P; Soria, V; López-García, P

López-García, P (通讯作者),Carlos III Hlth Inst, Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain.;López-García, P (通讯作者),Univ Autonoma Madrid, Sch Med, Dept Psychiat, 4 Arzobispo Morcillo St, Madrid 28029, Spain.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2023; 121 ():

Abstract

Background: Although there is scientific evidence of the presence of immunometabolic alterations in major depression, not all patients present them. R......

Full Text Link